Fritextsökning
Innehållstyper
- 
                                
Viktor Hrvota dubblar vd-skapet – tar över Umecrine Cognition
Umecrine Cognition har utsett Viktor Drvota till ny vd efter avgående Anders Karlsson.
 - 
                                
Noxious parasite forms hybrids and deceives the immune system
The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to decei...
 - 
                                
Halsfluss i fokus när Magnus Gisslén ryter vidare
Magnus Gissléns sågning av Folkhälsomyndigheten (FHM) fortsätter och nu riktar han ljuset mot användning av antibiotika vid halsfluss. Han kritiserar också nätv...
 - 
                                
The Swedish Academy of Sciences: “We have too many researchers”
Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.
 - 
                                
New drug alert in the US: Rise in overdoses linked to the use of drugs for animals
A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in t...
 - 
                                
Gilead står fast vid hivsatsning – trots hotad finansiering
Gilead Sciences planerar fortfarande att leverera sitt hiv-läkemedel till låginkomstländer om det godkänns i USA, trots osäker finansiering efter Trumpadministr...
 - 
                                
Webinar: Clinical evaluation and clinical investigation of medical devices
Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.
 - 
                                
She is Sweden´s new Minister of Healthcare
Today, Tuesday, Swedish Prime Minister Ulf Kristersson, who leads the Moderate Party and the centre-right coalition in Sweden, presented the government's new mi...
 - 
                                
Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages
For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...
 - 
                                
“We aim to be a start-up company with an academic spirit”
Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...
 - 
                                
Bioscience – Groundbreaking Research & Diagnostics: Stockholm (2026)
 - 
                                
Novo Nordisk vill ha skadestånd efter misslyckat miljardförvärv
Novo Nordisk vill ha ett skadestånd på upp till 830 miljoner dollar från KBP Biosciences, enligt ett domslut från en domstol i Singapore.
 - 
                                
Svenska forskare fann ”mellanform av parkinson och alzheimer”
Vissa patienter som får diagnosen Parkinsons sjukdom kan i själva verket ha en annan sjukdom som snarare liknar alzheimer. Det enligt en ny studie från Umeå och...
 - 
                                
One last chance to register for the premier metrology event in 2024
ZEISS QUALITY INNOVATION SUMMIT.
 - 
                                
Giulia Gaudenzi: Innovation for good
"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...
 - 
                                
The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time
According to a compilation from the Swedish Medicines Agency, the number of residually notified medicines increased by 54 % in Sweden last year compared to the ...
 - 
                                
Accelerate your Research with AI-Powered Image Analysis
Comprehensive eBook from ZEISS.
 - 
                                
Strömhopp från Novos styrelse – extra stämma utlyst
Större delen av styrelsen i danska läkemedelsjätten Novo Nordisk hoppar av efter oenighet med huvudägaren Novo Nordisk Foundation.
 - 
                                
Webinar: How to Plan And Analyze a Real-World Evidence Study
This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.
 - 
                                
Study: Semaglutide tablet produces weight loss
The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.
 - 
                                
Svenske Martin Kulldorff bland nya vaccinrådgivare – utnämnd av Kennedy
USA:s hälsominister Robert Kennedy Jr. utsåg på onsdagen åtta nya ledamöter till CDC:s rådgivande vaccinkommitté (ACIP), efter att plötsligt ha avskedat hela de...
 - 
                                
Meeting with focus on South Korea and Japan’s life sciences
Large, complex and exciting – this is how Britta Stenson, Business Sweden, describes the life science markets of Japan and South Korea, which took centre stage ...
 - 
                                
Misslyckande för BMS i sen studie om hjärtläkemedel
Läkemedelsjätten Bristol Myers Squibbs läkemedel mot en typ av hjärtsjukdom misslyckades i en sen klinisk studie. Det svaga utfallet ökar kraven på positiva utf...
 - 
                                
The most important Swedish medical innovations: Our ranking
Life Science Sweden turns 20 years old – and celebrates by producing a top list of the 20 most important contemporary Swedish innovations in the field of medicine.